Status:
UNKNOWN
Efficacy of Peri-neural Platelet Rich Plasma Injection in Treatment of Chemotherapy Induced Peripheral Neuropathy.
Lead Sponsor:
South Egypt Cancer Institute
Conditions:
Chemotherapy-induced Peripheral Neuropathy
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This study aims to show the efficacy and safety of ultra-sound guided peri-neural platelet rich injection in treatment of chemotherapy induced peripheral neuropathy.
Detailed Description
This study is prospective, randomized, assessor blinded controlled trial. It is aims to study the effect of perineural platelet rich plasma injection in cancer patients with prepheral neuropathy despi...
Eligibility Criteria
Inclusion
- cancer patients with peripheral neuropathy confirmed by clinical evaluation and nerve conduction study despite of medical treatment
Exclusion
- patients with:
- Foot ulcers and / or amputation.
- Peripheral vascular disease.
- Uncontrolled diabetes
- Vertebral pathologies.
- Connective tissue diseases.
- Thyriod disorders, significant renal or hepatic dysfunction.
- Platelet dysfunction syndrome, critical thrombocytopenia.
- Septicemia and local infection at the site of the procedure.
- Systemic corticosteriod adminstiration or local injection at the suspected treatment site within the last month.
- Recent fever or illness.
- Hemoglobin level less than 10 g/dl, platelet count less than 105-109/L.
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2024
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT05348408
Start Date
April 1 2022
End Date
April 1 2024
Last Update
April 27 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.